NETCast

Welcome to NETCast! Today's episode is "Immunotherapy: Past, Present and Future Directions." Our guest moderator, Renuka Iyer, MD, Roswell Park Comprehensive Cancer Institute, Buffalo, NY, is a medical oncologist and longtime NANETS member, currently serving on its Board of Directors. Dr. Iyer is the Co-Director of Roswell Park's Liver and Pancreas Tumor Center, Section Chief for Gastrointestinal Oncology, Department of Medicine, and Vice Chair of Faculty Recruitment & Retention. She is also Professor of Medicine at Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo.s

Dr. Iyer's guests for the episode are Namrata (Neena) Vijayvergia, MD, medical oncologist at Fox Chase Cancer Center. Dr. Vijayvergia is Assistant Chief, Gastrointestinal Medical Oncology, Associate Professor, Department of Hematology/Oncology, and Medical Director, Medical Oncology. She is also an active member of NANETS, where she has served on several committees in leadership roles, including immediate past chair of the Diversity & Membership Committee, past member, Mentoring & Early Career Development Committee, and currently serving on the Scientific Review & Research Committee.

Also joining as a guest is Sandip Patel, MD, Professor of Medical Oncology, University of California San Diego. Dr. Patel focuses on phase 1 immunotherapy trials and thoracic oncology immunotherapy trials. His research focus is on predictive biomarkers for immunotherapeutic response and generation of personalized cancer immunotherapy regimens.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

The topic of today's episode of NETCast is "Beyond Somatostatin Analogs." Our guest moderator is Dr. Junaid Arshad, Assistant Professor of Medicine and faculty member of GI Medical Oncology at the University of Arizona. Dr. Arshad received his medical degree from King Edward Medical University, Lahore, Pakistan and completed his Internal Medicine Residency at St. Mary's Hospital, Waterbury, CT. Dr. Arshad is a Clinical and Translational Scientist with a focus on developing novel therapeutics for several areas of Upper GI Oncology. He is a member of NANETS' Communications Committee.

Dr. Arshad is joined by two distinguished NET medical experts:

Dr. Emily Bergsland is a medical oncologist at the University of California, San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center who specializes in gastrointestinal malignancies. She is a Professor of Medicine, Director of the UCSF Center for Neuroendocrine Tumors, and serves as Associate Director for Education for the UCSF Helen Diller Family Comprehensive Cancer Center. Dr. Bergsland leads a clinical-translational research program focused on neuroendocrine neoplasms of all grades, which includes clinical trials and collaborative studies related to biomarkers, imaging and clinical outcomes. She is past president of the North American Neuroendocrine Tumor Society, a longstanding member of the NCCN Neuroendocrine Tumor Guidelines panel, and past chair of the NET Task Force of the NCI Gastrointestinal Steering Committee.

Dr. Pamela Kunz is an Associate Professor of Internal Medicine (Medical Oncology); Director, Center for Gastrointestinal Cancers at Smilow Cancer Hospital and Yale Cancer Center; Chief, GI Medical Oncology; Vice Chief, Diversity, Equity, and Inclusion. Prior to joining Yale, Dr. Kunz was Director of the Stanford Neuroendocrine Tumor Program, Leader of the Endocrine Oncology Research Group, and Director of the Neuroendocrine Tumor Fellowship. She is an international leader in the clinical care of patients with neuroendocrine tumors (NETs) and is advancing the field through clinical trials and translational science that are defining the next generation of therapies for patients with this rare diagnosis. Dr. Kunz is the current president of the North American Neuroendocring Tumor Society.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In today's episode, we reprise the NET Year in Review lecture, originally presented by NANETS president, Dr. Pamela Kunz, at the 2022 NET Medical Symposium in Washington DC. Dr. Kunz is an Associate Professor of Internal Medicine (Medical Oncology); Director of the Center for Gastrointestinal Cancers at Smilow Cancer Hospital and Yale Cancer Center; Chief, GI Medical Oncology; Vice Chief, Diversity, Equity, and Inclusion, Medical Oncology at Yale School of Medicine.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Listen in for this discussion recorded live from NANETS Annual conference with Dr. Alexandra Gangi, Cedars Sinai Medical Center as moderator, and Dr. Sandy Kotiah, Mercy Medical Center, and Dr. Mark Lewis, Intermountain Healthcare, as guests.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Tune in for this live discussion recorded from NANETS annual conference and moderated by Dr. Jason Starr, Mayo Clinic, and featuring guests Dr. Jennifer Eads, Penn Medicine, and Dr. Aman Chauhan, University of Kentucky Markey Cancer Center.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Tune in for a lively debate on when, when not to, and if  one should operate, with Diane Reidy-Lagunes, MD, Vice Chair of Oncology Operations, Regional Cancer Network; Past President, MSK Medical Staff; Creator and Host, Cancer Straight Talk Podcast, and past NANETS board member; and James Howe, MD, Professor of Surgery, Co-Director, Neuroendocrine Cancer Clinic, Director of Surgical Oncology and Endocrine Surgery, University of Iowa Carver College of Medicine, and past NANETS President; with guest moderator, Alexandra Gangi, MD, Associate Program Director, Complex General Surgical Oncology Program, Director Gastrointestinal Tumor Program, Cedars Sinai, and Chair, NANETS Communications Committee.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Tune in to listen as leading NET medical experts from different areas of specialization discuss and debate key factors that are critical in diagnosing and treating NET patients.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

NETCast, brought to you by the North American Neuroendocrine Tumor Society (NANETS).

Our episodes host leading neuroendocrine experts who will discuss the latest research, debate pros and cons of various treatment protocols, share information about establishing neuroendocrine centers, and much more. 

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.